Pharma Consulting | Strategic Consulting
Pharmaceutical Consulting
About Us
We are Razrbiopharm (www.razrbiopharm.com) an offshore company with offices in New Jersey,
USA and Bangalore, India that provides strategic consulting services to executives in the
Pharmaceutical and Biotech Industries.
Our primary focus is:
•
•
•
•
•
•
•

Strategic Marketing Analytics
Market evaluation for new markets, indications etc.
Opportunity Assessments and Sales forecasting
Strategic Evaluation of Business Development and licensing deals
Primary & Secondary Market Research
Clinical trial site identification in Asia (specifically India)
The firm is managed by individuals experienced in Drug Development, Strategic Marketing and
Finance and can be contacted at:

USA:
PJ Lavsi-CEO
pjlavsi@razrbiopharma.com
Ph: 908-328-5518

India:
Ram Narayan-Chairman
ramnarayan@razrbiopharma.com
Ph: +91-9844012534
Pharmaceutical Consulting
Value Proposition - Quality & Innovation at a Lower Cost
High-Quality analytics and innovative solutions driven by:
•
•
•

Custom research evaluation in healthcare industry with rapid turnaround times
Industry experience (US, Europe & Asia) and therapeutic knowledge of founders
& team members
Work-culture conducive to new idea generation and innovative thinking and high
quality research

Compelling Cost and Time and Extension of Resources Advantages
•
•

Reduced fixed costs through outsourcing
Reduced down time for client because of time zone advantage
Pharmaceutical Consulting
Key Offerings
Business Intelligence and Analysis
•
•
•
•
•
•

New Product and Technology Assessment
Revenue Forecasting and Asset Valuation
Competitive Intelligence
Performance Measurement and Decision Analysis
Cost and Treatment Analysis
Market Evaluation-Regional & Global

Project Management Services
•
•
•

Strategic Opportunity Assessments and Market Entry Strategies
Benchmarking
Clinical Site and KOL Evaluation In Asia
Pharmaceutical Consulting
Business Intelligence and Analysis – Key Offerings
Services Offered and Description
Forecasting and Asset
Valuation



Product/market forecasting, asset valuation and licensing , deal
structuring services.

Competitive
Intelligence



Gathering primary and secondary competitive intelligence and
quantifying impact on product. Market Evaluation

Patient Flow and Cost
Analysis



Determining patient treatment flow and modeling cost of
treatment.

Performance
Measurement



Producing routine monthly/quarterly sales, market and competitive
intelligence reports.
Pharmaceutical Consulting
Project Management Services – Key Offerings
Services Offered and Description
Strategic Opportunity
Assessment



Evaluation, Strategic options, benchmarking and planning.

Clinical Site & KOL
Evaluation in Asia



Development of clinical sites and evaluation of KOL treatment
algorithms

Compliant
Manufacturing Site
Proposal



Forecasting optimal asset allocation to achieve compliant
manufacturing.
Pharmaceutical Consulting
Experienced Leaders
Ram Narayan B.Sc., M.Sc.,PhD. Pharm.(Bel.)
Broad range of experience in pharmaceutical industry in marketing and business
development for over 20 years

Premal Lavsi B.Com, A.C.A., CPA
Over 25 years of experience in marketing and finance with Global pharmaceutical
companies like Bristol-Myers Squibb, Hoechst and Sanofi- Aventis. Experienced in
strategic planning, new product development, business strategy and
commercialization
Pharmaceutical Consulting
The In-House Team
•
•
•
•

Business Analysts (2) – B.Pharm/MBA; domain experts.
Market Research Expert (1) – MS Statistics, Market Research Experience
Statistician (1) – Ph.D. Statistics
Software Developers (2) – B.S./ M.S.; software development both web-based and stand-alone

Advisors
H. Badri MD, MBBS
Medical Advisor Novo Nordisk India
Chief Medical Advisor Anglo French India
Involved in phase III trials in critical bleeds of Novo 7
A K Goel
Vice President Carewell Technologies and Products
Senior Director SKF Pharma India
Involved in phase III trials of cimitidine
PhD Oxford
Pharmaceutical Consulting
Razr’s Case Studies
•

Completed an evaluation of basic research companies in the Indian market
$500M+ company

•

Completed a review of target Oncology companies to evaluate acquisition
opportunities-$1b + Pharma co. & a mid size biotech company. Large specialty
pharma company

•

Completed a strategic review of the Global Oncology marketplace -$2B + Large
Pharma

•

Completed a review of Oncology distribution practices in the Indian market- Large
Japanese Company

•

Completed an opportunity assessment for a PG x test in obesity-Start-up

•

Completed a review of the bio-similar market in India-$500M + biologics company
Pharmaceutical Consulting
Why Razr Biopharm
•

Broad-based analytical capabilities both primary & secondary
strategic research

•

Broad-based experience of team & leaders-Science, Business
and Marketing

•

High-Quality Analytics Done Rapidly

•

Potential for significant cost savings
Contact Today
RazrBiopharm

OR
Call: 91-908-328-5518

Pharmaceutical Consulting Firm

  • 1.
    Pharma Consulting |Strategic Consulting
  • 2.
    Pharmaceutical Consulting About Us Weare Razrbiopharm (www.razrbiopharm.com) an offshore company with offices in New Jersey, USA and Bangalore, India that provides strategic consulting services to executives in the Pharmaceutical and Biotech Industries. Our primary focus is: • • • • • • • Strategic Marketing Analytics Market evaluation for new markets, indications etc. Opportunity Assessments and Sales forecasting Strategic Evaluation of Business Development and licensing deals Primary & Secondary Market Research Clinical trial site identification in Asia (specifically India) The firm is managed by individuals experienced in Drug Development, Strategic Marketing and Finance and can be contacted at: USA: PJ Lavsi-CEO pjlavsi@razrbiopharma.com Ph: 908-328-5518 India: Ram Narayan-Chairman ramnarayan@razrbiopharma.com Ph: +91-9844012534
  • 3.
    Pharmaceutical Consulting Value Proposition- Quality & Innovation at a Lower Cost High-Quality analytics and innovative solutions driven by: • • • Custom research evaluation in healthcare industry with rapid turnaround times Industry experience (US, Europe & Asia) and therapeutic knowledge of founders & team members Work-culture conducive to new idea generation and innovative thinking and high quality research Compelling Cost and Time and Extension of Resources Advantages • • Reduced fixed costs through outsourcing Reduced down time for client because of time zone advantage
  • 4.
    Pharmaceutical Consulting Key Offerings BusinessIntelligence and Analysis • • • • • • New Product and Technology Assessment Revenue Forecasting and Asset Valuation Competitive Intelligence Performance Measurement and Decision Analysis Cost and Treatment Analysis Market Evaluation-Regional & Global Project Management Services • • • Strategic Opportunity Assessments and Market Entry Strategies Benchmarking Clinical Site and KOL Evaluation In Asia
  • 5.
    Pharmaceutical Consulting Business Intelligenceand Analysis – Key Offerings Services Offered and Description Forecasting and Asset Valuation  Product/market forecasting, asset valuation and licensing , deal structuring services. Competitive Intelligence  Gathering primary and secondary competitive intelligence and quantifying impact on product. Market Evaluation Patient Flow and Cost Analysis  Determining patient treatment flow and modeling cost of treatment. Performance Measurement  Producing routine monthly/quarterly sales, market and competitive intelligence reports.
  • 6.
    Pharmaceutical Consulting Project ManagementServices – Key Offerings Services Offered and Description Strategic Opportunity Assessment  Evaluation, Strategic options, benchmarking and planning. Clinical Site & KOL Evaluation in Asia  Development of clinical sites and evaluation of KOL treatment algorithms Compliant Manufacturing Site Proposal  Forecasting optimal asset allocation to achieve compliant manufacturing.
  • 7.
    Pharmaceutical Consulting Experienced Leaders RamNarayan B.Sc., M.Sc.,PhD. Pharm.(Bel.) Broad range of experience in pharmaceutical industry in marketing and business development for over 20 years Premal Lavsi B.Com, A.C.A., CPA Over 25 years of experience in marketing and finance with Global pharmaceutical companies like Bristol-Myers Squibb, Hoechst and Sanofi- Aventis. Experienced in strategic planning, new product development, business strategy and commercialization
  • 8.
    Pharmaceutical Consulting The In-HouseTeam • • • • Business Analysts (2) – B.Pharm/MBA; domain experts. Market Research Expert (1) – MS Statistics, Market Research Experience Statistician (1) – Ph.D. Statistics Software Developers (2) – B.S./ M.S.; software development both web-based and stand-alone Advisors H. Badri MD, MBBS Medical Advisor Novo Nordisk India Chief Medical Advisor Anglo French India Involved in phase III trials in critical bleeds of Novo 7 A K Goel Vice President Carewell Technologies and Products Senior Director SKF Pharma India Involved in phase III trials of cimitidine PhD Oxford
  • 9.
    Pharmaceutical Consulting Razr’s CaseStudies • Completed an evaluation of basic research companies in the Indian market $500M+ company • Completed a review of target Oncology companies to evaluate acquisition opportunities-$1b + Pharma co. & a mid size biotech company. Large specialty pharma company • Completed a strategic review of the Global Oncology marketplace -$2B + Large Pharma • Completed a review of Oncology distribution practices in the Indian market- Large Japanese Company • Completed an opportunity assessment for a PG x test in obesity-Start-up • Completed a review of the bio-similar market in India-$500M + biologics company
  • 10.
    Pharmaceutical Consulting Why RazrBiopharm • Broad-based analytical capabilities both primary & secondary strategic research • Broad-based experience of team & leaders-Science, Business and Marketing • High-Quality Analytics Done Rapidly • Potential for significant cost savings
  • 11.